Germany· DE-A57-076347d2a7f637bb
Natrixam
A medicinal product containing indapamide, amlodipine besilate, registered in Germany by Les Laboratoires Servier (Suresnes).
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Indapamide, Amlodipine Besilate
- Manufacturer
- Les Laboratoires Servier (Suresnes)
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Indapamide, amlodipine besilate in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceNATRIXAM 1,5 mg/10 mg, comprimé à libération modifiéeBB FARMA (ITALIE)
- NetherlandsFlutensif 1,5 mg / 10 mg, tabletten met gereguleerde afgifteLes Laboratoires Servier
- FinlandFlutensifLes Laboratoires Servier
- PolandTertens-AMLes Laboratoires Servier
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Fludexam
- Bulgaria · Натриксам
- Estonia · Flutensif, Natrixam
- France · Natrixam
- Croatia · Natrixam
- Hungary · Cardilopin Komb
- Italy · Frecanstal
- Lithuania · Natrixam
- Luxembourg · Natrixam
- Latvia · Tertensam
- Malta · Natrixam
- Netherlands · Flutensif, Natrixam
- Poland · Tertens-Am
- Portugal · Flutensif, Natrixam
- Romania · Fludexam, Natrixam
- Slovenia · Nadexam
- Slovakia · Flutensif, Natrixam
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f33fe55e-c83e-49cd-b516-3984fbefe4d5 GET /v1/drugs/f33fe55e-c83e-49cd-b516-3984fbefe4d5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Indapamide, Amlodipine Besilate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about indapamide, amlodipine besilate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.